BMSC further enhance the myeloma-induced immune dysfunction, by secreting factors such as VEGF, HGF, fibroblast growth factor (FGF), and stromal-cell-derived factor (SDF)-1α. This evidence concerns the gene HGF and plasma cell myeloma.